
About Radolabs Limited
Data last updated:
Radolabs Limited is a public limited company based in Chennai, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 21 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24299TN2020PLC136576. Its GSTIN is 33AAKCR2898A1ZC (Tamil Nadu).
The company has an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹4.66 Cr. It is led by directors including Atul Dave and Jothi Valentine Kirubakaran.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Chennai, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹14.72 Cr, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹1.27 Cr (net margin 8.6%) and EBITDA of ₹3.89 Cr (EBITDA margin 26.4%). Revenue has grown at a compounded annual rate (CAGR) of 93% over three years.
The company is associated with 1 brand: Radolabs. As per MCA filings, the company has open charges of ₹11.26 Cr on record. Court records list 10 cases involving the company, including 10 filed against it; 7 cases are pending. The company has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹1.37 Cr; the latest was in March 2022. Its 4 peer companies in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities) are compared by revenue, 1 larger and 3 smaller; the largest is Deeptek Medical Services Private Limited with revenue of ₹14.76 Cr. The company has 6 MSME Form 1 returns on record between 2021 and 2023, listing 46 overdue payments to 22 micro and small suppliers.
Radolabs Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0043292). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website radolabs.in.
Company details
CIN history
Radolabs has one previous CIN (Corporate Identification Number): U24299TN2020PTC136576. The current CIN is U24299TN2020PLC136576, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24299TN2020PLC136576 | Current |
| U24299TN2020PTC136576 | Previous |
Recognitions & Rankings of Radolabs
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-02-0043292
Contact details
Radolabs Limited's registered office is in Chennai, Tamil Nadu.
- Registered AddressAsv Hansa Towers No.53, Thousand Lights East, Chennai, Tamil Nadu, India – 600006
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Radolabs operates one associated brand: Radolabs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides lab tests, ultrasound scans, and health packages in Chennai. | radolabs.in |
Business activity
The main business activity of Radolabs is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Radolabs Limited, buy the company report.
Financials of Radolabs Limited
FY 2024 filings availableRadolabs Limited reported revenue of ₹14.72 Cr (up 36% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 93% over three years, including 36% growth in the latest year. EBITDA rose 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹3.89 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹1.27 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 26.4% | |||
| Net Profit Margin | 8.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Radolabs Limited, buy the company report.
Board of directors and KMP of Radolabs Limited
Radolabs Limited currently reports 3 directors and 1 key managerial person. 3 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Atul Dave | Additional Director | 26 May 2025 | 1 Years 4 Months | Current |
| Jothi Valentine Kirubakaran | Additional Director | 22 Oct 2024 | 2 Years 0 Months | Current |
| Silvester Brighton Also directs: Antov Home Appliances Limited | Ceo | 18 Feb 2021 | 5 Years 8 Months | Current |
| Komandur Rajgopalan Ravi Kumar | Additional Director | 26 May 2025 | 1 Years 4 Months | Current |
Peer comparison
Radolabs Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Deeptek Medical Services Private Limited | ₹14.76 Cr (FY 2024) | 102.0% | Pune, Maharashtra, India | |||
| Radolabs Limitedthis company | ₹14.72 Cr (FY 2024) | ₹1.27 Cr | 8.6% | 36.0% | Chennai, Tamil Nadu, India | |
| L7h Life Resources Private Limited | ₹14.65 Cr (FY 2025) | 9.0% | Bangalore, Karnataka, India | |||
| Multispeciality Lab Services Private Limited | ₹14.39 Cr (FY 2021) | -2.0% | Tiruchirappalli, Tamil Nadu, India | |||
| Neuberg Magnum Imaging & Diagnostics Private Limited | ₹14.36 Cr (FY 2024) | 5.0% | Tiruchirappalli, Tamil Nadu, India |
To see the full peer comparison of Radolabs Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Apr 2024 | 100911707 | Others | ₹29.2 Lakh | Open | |
| 17 Apr 2024 | 100931820 | State Bank of India | ₹3.8 Cr | Open | |
| 31 Mar 2024 | 100911245 | Others | ₹1.52 Cr | Open | |
| 12 Dec 2023 | 100833006 | Others | ₹33.15 Lakh | Open | |
| 30 Apr 2023 | 100723583 | Others | ₹1.3 Cr | Open |
To see the full charge records of Radolabs Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Radolabs Limited has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹1.37 Cr; the latest was in March 2022.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Rights issue | ₹1.9 Cr | Investors: 3 individuals |
| Apr 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 3 individuals |
| Mar 2021 | Funding round | ₹50 Lakh | Investors: 4 individuals |
| Dec 2020 | Funding round | ₹87.2 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Radolabs Limited has 10 court cases on record: 10 filed against it. 7 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 6 | 5 |
| High courts | 4 | 4 | 2 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chengalpattu, Tamil Nadu | Criminal complaint | Filed against the company by Medblue Labs Private Ltd Rep by Its Director Mr. Madhukar Choudary | Pending |
| District court, Chengalpattu, Tamil Nadu | Criminal miscellaneous application | Filed against the company by Medblue Labs Private Limited Rep by Its Director Madhukar Choudary | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Kotak Mahindra Bank Limited | Pending |
| District court, New Delhi, Delhi | Cheque dishonour complaint | Filed against the company by Siemens Financial Services Pvt Ltd | Pending |
| District court, Chengalpattu, Tamil Nadu | Criminal miscellaneous application | Filed against the company by Medblue Labs Private Limited Rep by Its Director Madhukar Choudhary | Disposed |
To see the full case history of Radolabs Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Radolabs Limited has 6 MSME Form 1 returns on record between 2021 and 2023, listing 46 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 22)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Suganj Eco Chemicals Private Limited | |||
| Esteem Scientific Products | |||
| Senthil Biomedical Distributors | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Radolabs Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Radolabs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAKCR2898A1ZC | Tamil Nadu | Active | 09 Nov 2020 |
To see the full GST registrations and return filing status of Radolabs Limited, buy the company report.
Recent activity
Radolabs Limited has 7 board changes on record since 2021: 4 appointments and 3 cessations. The latest: Atul Dave was appointed as Additional Director on 26 May 2025.
10 earlier events are in the company report.
Frequently asked questions
Radolabs is an active public limited company based in Chennai, Tamil Nadu, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 21 July 2020 (6+ years old) and is registered under CIN U24299TN2020PLC136576.
Radolabs has 4 current directors and KMP:
- Atul Dave - Additional Director
- Jothi Valentine Kirubakaran - Additional Director
- Komandur Rajgopalan Ravi Kumar - Additional Director
- Silvester Brighton - Ceo
The latest financial statements of Radolabs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Radolabs is 33AAKCR2898A1ZC, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Radolabs is U24299TN2020PLC136576. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Radolabs has 10 court cases on record: 10 filed against it. 7 are pending. Most are in the district courts.
Radolabs was incorporated on 21 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Chennai.
Radolabs has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹1.37 Cr; the latest was in March 2022.
The peers of Radolabs by revenue are Deeptek Medical Services Private Limited, L7h Life Resources Private Limited, Multispeciality Lab Services Private Limited, Neuberg Magnum Imaging & Diagnostics Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).
Atul Dave was appointed as Additional Director on 26 May 2025. Komandur Rajgopalan Ravi Kumar was appointed as Additional Director on 26 May 2025. Jothi Valentine Kirubakaran was appointed as Additional Director on 22 Oct 2024. Radolabs has 7 board changes on record in total.
Yes, Radolabs is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Radolabs is registered as a small enterprise under Udyam registration (number: UDYAM-TN-02-0043292).